Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Chemokines and chemokine receptors in multiple sclerosis.
Thrombotic thrombocytopenic purpura-haemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon beta.
Correlation of midkine serum level with pro- and anti-inflamatory cytokines in multiple sclerosis.
Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.
Comparison of LC-UV and LC-MS methods for simultaneous determination of teriflunomide, dimethyl fumarate and fampridine in human plasma, application to rat PK study.
Cohort Study Comparing the Berg Balance Scale and the Mini-BESTest in Ambulatory People With Multiple Sclerosis.
The Effect of a Creative Art Program on Self-Esteem, Hope, Perceived Social Support, and Self-Efficacy in Individuals With Multiple Sclerosis: A Pilot Study.
Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.
Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.
Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry.
Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Evaluation of the effects of reflexology on quality of life and symptomatic relief in multiple sclerosis patients with moderate to severe disability; a pilot study.
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.
Characterization of the first K(+) channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris.
Compromised motor imagery ability in individuals with multiple sclerosis and mild physical disability: An ERP study.
The clinical relevance of force platform measures in multiple sclerosis: a review.
Suppression of IL-10 production by calcitriol in patients with multiple sclerosis.
Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2.
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination.
Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?
Orientational ordering of carotenoids in myelin membranes resolved by polarized Raman microspectroscopy.
Simvastatin in patients with progressive multiple sclerosis.
Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability.
Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury.
Pages
« first
‹ previous
…
360
361
362
363
364
365
366
367
368
…
next ›
last »